Mallinckrodt Pharmaceuticals
MNK
$0.34
Share price
0.00%
Change (1 day)
-93.81%
Change (1 year)
Categories
P/S ratio for Mallinckrodt Pharmaceuticals (MNK)
P/S ratio as of May 2024 (TTM): 0.0023
According to Mallinckrodt Pharmaceuticals 's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 0.00233125. At the end of 2023 the company had a P/S ratio of 0.0080.
P/S ratio history for Mallinckrodt Pharmaceuticals from 2013 to 2023
PS ratio at the end of each year
| Year | P/S ratio | Change |
|---|---|---|
| 2023 | 0.0080 | -84.97% |
| 2022 | 0.0533 | 1012.11% |
| 2021 | 0.0048 | -37.59% |
| 2020 | 0.0077 | -91.72% |
| 2019 | 0.0928 | -81.11% |
| 2018 | 0.4914 | -18.72% |
| 2017 | 0.6046 | -58.19% |
| 2016 | 1.45 | -36.78% |
| 2015 | 2.29 | -43.03% |
| 2014 | 4.02 | 197.43% |
| 2013 | 1.35 |
P/S ratio for similar companies or competitors
| Company | P/S ratio | P/S ratio differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | 3.92 | 167,895.28% | 🇺🇸 USA |
 General Electric GE | 2.51 | 107,761.45% | 🇺🇸 USA |
 Zogenix ZGNX | N/A | N/A | 🇺🇸 USA |
 Teva Pharmaceutical Industries TEVA | 0.9993 | 42,763.79% | 🇮🇱 Israel |